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MEMBRANE  IMMUNOGLOBULINS  OF  B  LYMPHO- 
CYTES 
Inability to Detect Certain Characteristic  IgM  and IgD Antigens* 
BY S.  M.  FU  AND H.  G.  KUNKEL 
(From The Rockefeller  University,  New York  10021) 
Evidence  from  studies  of normal  human  peripheral  blood  lymphocytes and 
leukemia lymphocytes of patients  with chronic  lymphocytic leukemia  (CLL) 1 
indicates that  IgM  and  IgD  are  the  predominant receptor  Igs  on  the  human 
lymphocyte surface (1-3). They occur together on the same cell surface in many 
but not all instances. Little is known about their interrelationship although it has 
been  demonstrated that  they form  caps  independently  (3).  In  the  course  of 
analyzing these surface Igs and studying their relationship to each other it was 
observed that not all IgM and IgD antisera with well defined antibodies to the 
serum  Igs  detected  them  on  the  lymphocyte  surface.  The  present  report 
represents a detailed investigation of this phenomenon and demonstrates that a 
part of the Fc fragment is unavailable for reaction with specific antibodies. 
Materials and Methods 
Preparation  of IgM and Its Fragments.  Two IgM K and two IgM )~ proteins were isolated from 
defibrinated plasma of patients with WaldenstrSm's macroglobulinemia by Pevikon (Mercer Corp. 
Yonkers, N.  Y.)  block electrophoresis. One IgM ~ and one IgM  h  proteins further purified by gel 
chromatography on Sephadex G-200 (Pharmacia Chemical Co., Uppsala, Sweden). Partial reduction 
and alkylation of the IgM K  and the IgM h were made by reduction with 0.02 M dithiothreitol followed 
by alkylation with 0.03 M iodoacetamide at pH 8.0.  Complete reduction and alkylation of these two 
proteins were carried similarly in 5 M guanidine HC[. The completely reduced and alkylated IgM 
was soluble in phosphate-buffered  saline (PBS) whereas the completely reduced and alkylated IgM K 
was insoluble. F(ab)~(pep) and F(ab')2~(pep) fragments were prepared from the IgM K according to 
Schrohenloher and  Bennett (4).  The IgM  was incubated with  ¼00  weight of pepsin (Worthington 
Biochemical Corp.,  Freehold, N.  J.)  in  0.1  M  sodium acetate buffer (pH  4.1) for 2~2  h  at  37°C. 
Digestion was stopped by neutralization to pH 8. The resulting mixture containing the fragments was 
concentrated and applied to a Sephadex G-100 column. F(ab),(pep) fragments were obtained as the 
second peak  after the peak  of' the void volume of the column. The void volume peak contained 
* This investigation has been supported by U. S. Public Health Service grant no. RR-102  and AM 
09792. 
~Abbreviations  used in this paper: CLL, chronic lymphocytic leukemia; PBS, phosphate-buffered 
saline. 
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F(ab')2~(pep)  fragments and  undigested IgM.  Purified F(ab%~(pep) fragments were obtained by 
repeated gel chromatography on Sephadex G-150. 
F(c)5~(tryp)  fragments were obtained essentially according to the method of Plaut and Tomasi (5). 
Trypsin (Worthington) digestion of IgM was performed at 60°C for 3 h with a substrate-to-enzyme 
ratio 50:1  in 0.05  M Tris-HCl buffer, 0.015 M  calcium chloride (pH 8.1).  An equivalent amount of 
soybean trypsin inhibitor was added to the reaction mixture. The F(c),~ and F(ab)~ were separated by 
gel chromatography on Sephadex G-200.  F(c)5,(tryp) was obtained from the IgM K and the IgM ~. 
F(ab')2,(pep) and F(ab),(pep)  gave single precipitin lines in the gamma region with antisera to 
kappa type light chains on immunoelectrophoresis. F(ab)  (pep) did not react with anti-u specific 
antisera whereas F(ab%~(pep)  reacted with some anti-t*  antisera. F(c)5,(tryp)  formed a  precipitin 
line in the beta region with anti-t, antisera but not with antisera to kappa type light chains or antisera 
specific for Fab of IgG.  By agar diffusion analysis with anti-t* antiserum all three fragments were 
deficient antigenically when compared to the whole IgM and F(ab')2,(pep) and F(c)5,(tryp) showed 
reaction of nonidentity. F(ab),(pep) showed partial inhibition of the precipitin line fbrmed by anti-t* 
antiserum and F(ab')2,(pep). 
Anti-Immunoglobulin  Antisera.  Antisera  against  isolated  IgM  and  IgD  were  raised  in  New 
Zealand Red rabbits. For immunofluorescence, F(ab')~ fragments made from gammaglobulin fraction 
of  these  antisera  according  to  Nisonoff et  al.  (6)  were  conjugated  with  tetramethylrhodamine 
isothiocyanate. F(ab')~ fragments specific for t*  (Rho-anti-t*) and  F(ab')2  fragments specific for 5 
(Rho-anti-5) were made by appropriate absorptions and the specificity of these antisera was ascer- 
tained as previously reported (2). F(ab') fragments of Rho-anti-t* were obtained by mild reduction 
with 0.01  M  cysteine. Absorption with 0.1  mg F(ab')~,(pep) per  1 ml  of Rho-anti-t* abolished its 
ability to agglutinate F(b')2,(pep)-coated red  cells and its titer against F(c)s,-coated red  cells re- 
mained unaltered. Similarly, absorption with 0.1 mg F(c)~(tryp) per 1 ml of Rho-anti-t* abolished its 
ability  to  agglutinate  F(c)5,-coated  red  cells  and  its  titer  against  F(ab')~-coated cells  remained 
unchanged. Absorption of Rho-anti-t* and Rho-anti-~ with packed CLL cells was carried out at room 
temperature for 45  min. Antisera were absorbed at  a  ratio of 1 ml antiserum per 2.5  ×  10 ~ cells. 
Absorption of F(ab') fragments of Rho-anti-t* by CLL cells was carried out in a similar manner. These 
fragments  did  not  agglutinate  IgM-coated  cells  but  they  interfered  with  the  agglutination  of 
IgM-coated red  cells by an anti-t*  antiserum. For hemagglutination inhibition, the anti-t, antisera 
were used after absorption with Fraction II human gamma globulin. 
Lymphocyte  Preparation  and  Cell Fractionation.  Mononuclear  cells  were  isolated  from  the 
peripheral blood of patients with CLL with WBC greater than 25,000/mm 3 and normal subjects by 
Ficoll-Hypaque discontinuous gradients. The cells were washed six times with 50 ml PBS. Viability of 
lymphocyte preparations was greater than  95%  by  trypan  blue  exclusion.  For  cell fractionation, 
lymphocyte suspensions were subjected to sonication. After sonication, no intact lymphocytes were 
observed by microscopic examination. The homogenate was centrifuged at 133,000 g for 60 min. The 
sediment was  resuspended in  an  original  vol  of PBS.  The  homogenate, the  supernate,  and  the 
sediment were used for hemagglutination inhibition or absorption experiments. 
Hemagglutination  Inhibition and Antiserum Absorption.  Hemagglutination and hemagglutina- 
tion inhibition experiments were carried out as described previously (7). Purified proteins were coated 
onto human red cells by the bizdiazotized benzidine method (BDB). A lymphocyte suspension was 
incubated  with  an  equal  volume  of  the  appropriately  diluted  antiserum  for  45  min  and  after 
centrifugation, 0.1 ml of the supernate was used to test its ability to agglutinate indicator red cells. 
More than 90  95% lymphocytes were viable after absorption. Cell homogenate and sediment fractions 
were used for absorption of the diluted antiserum in an identical manner and the supernatant fraction 
was used as an inhibitor directly. By comparison of the absorption efficiency  of the cell suspensions in 
serial  dilution  and  known  amount  of  inhibitory  proteins,  the  gross  amount  of surface  Ig  was 
estimated.  Determinations of inhibitor protein  concentration were done  by  the  modified Folin- 
Ciocaulteau method. 
Immunofluorescence.  Immunofluorescent staining of lymphocyte surface Ig was performed as 
described by Pernis et al.  (8).  Since F(ab')2 fragments of Rho-anti-t* and Rho-anti-5 were used, no 
attempt was made to remove aggregates before use. Immunofluorescent staining of intracellular Ig of 
cells from the lymphoblast line RPMI 1788 was done according to Hijmans et al. (9). The cell line was 
obtained from Associated Biomedic Systems Inc.  (Buffalo,  N.  Y.)  and maintained in RPMI  1640 
culture medium supplemented with 10% fetal calf serum, penicillin, and streptomycin. S.  M.  FU  AND  H.  G.  KUNKEL  897 
Results 
Hemagglutination  Assays.  One  of  the  major  procedures  employed  in  the 
present  study  of  the  surface  Igs  was  essentially  an  antiserum  absorption 
technique utilizing viable lymphocytes. The degree of absorption of the specific 
antiserum  was  then  determined by hemagglutination using IgM,  IgD,  or their 
fragments as coat proteins on the red cells. It was initially observed in the case of 
IgM  that  not  all  the  antibodies  giving  specific  hemagglutination  could  be 
absorbed out by normal or CLL lymphocytes known to have IgM on their surface. 
Table  I  shows  the  results with  one  of the  IgM  systems  employed. The  upper 
portion of the table shows the specificity of the hemagglutination reaction using 
whole  IgM  as  the  red  cell  coat  and  an  antiserum  specific  for  IgM  as  the 
agglutinator. It can be seen that whole isolated IgM inhibited the agglutination 
as did the Fc fragments made by the trypsin procedure. However, Fab fragments 
did not inhibit nor did other Igs. The lower portion of Table I  shows the results 
with this system when IgM-bearing lymphocytes or their fractions were employed 
to  absorb  out  or  inhibit the  antiserum.  The  whole  cells  had  no  effect on  the 
hemagglutination even when high concentrations were used despite the fact that 
fluorescent antibody analyses clearly showed surface IgM. However, the homoge- 
nate of the  cells and the supernate fraction inhibited the antiserum even at low 
TABLE I 
Hemagglutination System Consisting of Red Cells Coated with Whole 
IgM and Anti-IgM Antiserum 
The upper portion shows the specificity of the system which is only inhibited by whole IgM or the Fc 
fragment. The lower part shows the effect of cells or their fractions in absorbing out or inhibiting the 
agglutinating  antiserum.  Whole cells had no effect while the homogenate was strongly inhibitory. 
Protein 
Inhibitor protein concentration (#g/ml) 
100  10  1  0.25  0.062  0.016 
IgM  0  0  0  0  0  2 
F(c),,(tryp)  0  0  0  0  0  2 
F(~b')2,(pep)  2  2  2  2  2  2 
F(ab),(pep)  2  2  2  2  2  2 
Pooled IgG  2  2  2  2  2  2 
IgD  2  2  2  2  2  2 
IgA  2  2  2  2  2  2 
Source of cells 
108 cells/ml 
1  0.5  0.25  0.125  0.062  0.031 
RF(CLL) Cells  2  2 
Homogenate  0  0 
Sediment  0  2 
Supernate  0  0 
SF(normal) cells  ND  2 
2  2  2  2 
0  0  0  2 
2  2  2  2 
0  0  0  2 
2  2  2  2 
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concentrations. Lymphocytes and their fractions from eight patients with CLL 
behaved in the same manner. Similar results were obtained with three different 
antisera and a variety of isolated IgM proteins as red cell coats. Agar diffusion 
analysis  indicated  that  all  of  these  antisera  contained  antibodies  primarily 
directed to the Fc portion of the molecule and were negative or weakly reactive to 
the various Fab fragments. 
Four  of  ten  IgM  specific  antisera  were  found  to  react  significantly  with 
F(ab')2,(pep) fragments in agar diffusion. When these antisera were employed 
and the F(ab')2,(pep) fragment was used as the red cell coat, strong agglutination 
was  obtained.  This system  is  shown  in Table II.  Whole IgM  and  the F(ab')~, 
fragments inhibited the reaction but the  Fc fragments were entirely negative. 
However,  in  contrast  to  the  previous  results,  whole  lymphocytes effectively 
removed  the  antibodies  so  that  the  agglutination  reaction  became  negative. 
Similar  results  were  obtained  when  whole  IgM  was  used  as  the  red  cell  coat 
provided that the antiserum had the additional absorption with Fc fragments. In 
each case anti-IgM antibodies directed against Fab sites probably near the hinge 
region  of the  molecule were  involved and  these were readily removed by  the 
lymphocytes.  These  systems  could  be  used  to  quantitate  the  IgM  on  the 
lymphocytes of normal individuals and CLL cases. Levels up to 1,000 ng/10  s cells 
were obtained for some of the  13 CLL cases studied. 
If IgM  systems  using  Fc  fragments  as  the  coat  were  employed with  whole 
antisera or antisera specific for the Fc region, the whole lymphocytes failed to 
TABLE II 
Hemagglutination  System Consisting of Red Cells Coated with F(ab)2,(pep) and 
Anti-IgM Antiserum 
In this system the CLL lymphocytes  absorb out the agglutinating antibodies and IgM is detected on 
the cell surface. 
Protein 
Inhibitor protein concentration (~g/ml) 
100  10  1  0.25  0.062  0.016 
IgM  0  0  0  0  1  2 
F(c)5.(tryp)  2  2  2  2  2  2 
F(ab)2.(pep)  0  0  0  0  0  2 
F(ab).(pep)  0  0  2  2  2  2 
Pooled IgG  2  2  2  2  2  2 
IgD  2  2  2  2  2  2 
IgA  2  2  2  2  2  2 
Source of cells 
10 8 cells/ml 
1  0.5  0.25  0.125  0.062  0.031 
RF(CLL)  0  0  0  0  0  2 
SF(normal)  ND  0  1  1  2  2 
Antiserum dilution  1/800.  Coating protein F(ab')2.  {pep}. S.  M.  FU  AND  H.  G.  KUNKEL  899 
remove enough antibodies to alter the hemagglutination. Evidence was obtained 
that some Fc antibodies were removed by the lymphocytes but enough antibodies 
always remained to give agglutination. IgMs obtained on partial reduction and 
alkylation behaved very similar to the whole IgM and reacted with antibodies 
that  the  lymphocytes failed  to  remove.  IgMs  after  complete  reduction  and 
alkylation failed to react  with antibodies  specific for Fc  and  Fab  fragments. 
Studies with IgG and IgA systems in a fashion similar to the above work with IgM 
did not detect any antigens belonging to these classes in the CLL cells examined. 
Lymphocytes and their fractions of one of the CLL patients did not absorb either 
Fc or Fab specific antibodies. However, immunofluorescent study confirmed that 
these lymphocytes possessed no surface IgM. 
Immunofluorescence.  In the initial studies, IgM was readily detected on the 
lymphocyte surface of the normal and CLL cells by fluorescence even though the 
first hemagglutination system described above failed to show surface IgM. This 
discrepancy was  one  of the findings that raised  the  possibility of buried IgM 
determinants on the lymphocyte surface. Both the anti-IgM Fc and the anti-IgM 
Fab antisera described above gave strong fluorescence of IgM-bearing cells. Some 
of these  data are  shown in Table  III.  The percentage of cells showing surface 
staining with the rhodamine-conjugated anti-IgM antiserum is indicated both for 
two normal and two CLL lymphocyte preparations. The IgM-specific antiserum 
TABLE  III 
Effect of Absorption  With CLL Cells  on the Detection of Surface and Intracellular IgM 
Surface  IgM  staining  is  virtually  eliminated  but  antibodies  giving  intracellular  staining  and 
agglutination remain. 
Surface immunofluorescence 
Normal  CLL 
SF  CD  RF  GO 
Intracellular 
immuno-  Hemag- 
fluorescence  glutionation 
titer against 
lympho- 
blastoid line  IgM-coated 
red cells 
RPMI 1788 
Rho-anti-tt 
Rho-anti-# absorbed by: 
F(ab')2~(pep) 
F(ab')2~(pep)  and  once  with 
CLL ceLls 
F(ab')~(pep)  and  twice  with 
CLL cells 
F(ab')2,(pep)  and  three  times 
with CLL cells 
F(ab')~,(pep)  twice  with  CLL 
cells and F(c)5~(tryp) 
no. positive 
% positive cells  cells*/200 
cells 
10  10  91  64  21 
11  9  92  67  21 
11  11  86  42  20 
<i  4  <i  <1  21 
<i  2  <i  <l  19 
ND  ND  ND  ND  0 
1/256 
1/256 
1/128 
1/128 
1/64 
0 
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shows  staining  of  approximately  10%  of  normal  lymphocytes  and  a  high 
percentage of the CLL cells. Similar staining was obtained after absorption of the 
antiserum  with  F(ab')2,(pep)  fragments.  After  additional  absorptions  with 
IgM-bearing CLL cells,  the  surface fluorescence reaction on normal and CLL 
cells  essentially disappeared.  However,  antibodies remained in  the  antiserum 
which gave strong agglutination and stained the intracellular Ig in the cells of a 
lymphoblastoid line. Approximately 10% of the cells of this line stained strongly 
with the unabsorbed antiserum. A similar percentage stained with the antiserum 
absorbed  with  viable  lymphocytes. This  staining and  the  agglutination only 
disappeared after absorption with the IgM Fc fragments. Similar results were 
obtained with lymphocyte absorptions of the F(ab') fragments of the specific IgM 
antibodies. These data and those from other similar experiments added further 
evidence that a portion of the Fc determinants of the lymphocyte membrane Ig is 
unavailable for reaction with the anti-Fc antiserum. 
Experiments were also carried out on the IgD system. Serial absorptions of 
IgD-specific antisera with IgD-bearing CLL cells abolished the surface staining of 
IgD-bearing lymphocytes but  left strong hemagglutinating activity just as  was 
the  case  for the  IgM system. In  one  experiment,  after three absorptions with 
lymphocytes, the  fluorescence was  completely abolished  but  a  1/320 titer  in 
hemagglutination remained.  The  hemagglutinating activity that  could not be 
absorbed  out with lymphocytes was shown to be specific for IgD in inhibition 
experiments. 
Discussion 
The observations described above indicate that viable lymphocytes with surface 
IgM  fail  to  react  with  a  population  of  anti-IgM  antibodies  found  in  most 
IgM-specific antisera. These antibodies are directed against the Fc part of the 
molecule and react strongly with isolated serum IgM as well as the intracellular 
IgM  of  both  lymphocytes  and  plasma  cells.  Absorption  experiments  with 
lymphocytes  failed  to  remove  these  antibodies  as  demonstrated  both  by 
hemagglutination and fluorescent antibody studies. Antisera made specific for 
the  Fab  portion  of  the  IgM  molecule  were  completely  removed  by  such 
lymphocyte absorptions.  It  also  was  apparent  that  not  all  of the  antibodies 
directed against Fc antigens were unavailable for reaction with the surface IgM; 
some  clearly  were  absorbed  out  with  lymphocytes. Some  evidence  has  been 
obtained that  the  C-terminal  part  of the  Fc  is  involved. Preliminary studies 
utilizing a  CH4 fragment obtained from IgM Fc by limited enzymatic digestion 
(10)  indicates  that  this  C-terminal  area  has  at  least  part  of the  antigenic 
determinants that are not detectable on the lymphocyte surface. 
Results  similar  to  those  for  IgM  were  obtained  for  IgD,  the  other  major 
membrane Ig of human peripheral blood lymphocytes. Somewhat less extensive 
studies were carried out with this system but clear evidence for an absence of Fc 
antigens was obtained in  absorption experiments where lymphocytes failed to 
remove a population of IgD antibodies. 
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that a portion of the Fc of the surface IgM and IgD molecule was different from 
those of the serum IgM and IgD and the most likely possibility is that it is buried 
in  the  lymphocyte  membrane  so  that  the  specific  antibodies  or  their  Fab 
fragments were unable to reach it. Other possibilities also require consideration. 
Additional carbohydrate may be  present on the membrane-bound IgM which 
might  change  the  availability of certain  antigenic  sites.  Some  differences in 
carbohydrate of surface IgM has been observed by Melchers and associates (11). 
A third possibility is that the amino acid structure is different. Most studies with 
lymphocyte surface radioiodination by the  procedures  developed by Uhr  and 
associates (12) have indicated that the g-chains were very similar for membrane 
and intracellular IgM. However, there have been some reports of differences in 
the size of the #-chain {13). It will be of interest to see if the membrane Ig after 
release  from  the  cell  with nonionic  detergents  will  then  react  with the  lym- 
phocyte-absorbed antisera. Such experiments should be feasible. 
Studies  have  been  carried  out  by  FrSland  and  Natvig  (14) on  IgG2  on 
lymphocytes that are relevant to the present observations. They found, by the 
use of genetic markers, that Gm(n) which has been localized to the pfc' fragment 
of the IgG molecule was not detectable. Pernis et al. (8) had similar results re- 
garding  surface  IgG  on  rabbit  lymphocytes. Other  workers  using  fluorescent 
antibody analyses in the IgA system have noted that not all IgA antisera reveal 
IgA on  the  membrane  2 (15). In the  present  studies all  IgM and IgD  antisera 
tested showed the surface Igs by the fluorescent antibody technique but it was 
only when  other techniques were utilized that the differences from serum Igs 
became apparent. Some previous observations (16) by techniques similar to the 
absorption-hemagglutination method employed in the present study failed to de- 
tect  IgM  on  the  CLL and  normal  lymphocyte surface. These  results are  now 
readily explainable as due to antibodies to the absent lymphocyte determinants 
which were not absorbed out and the agglutination was not altered. 
Recent findings on the amino acid sequence of the IgM heavy chains indicate 
that,  except for a  carbohydrate group attached to  residue  563, the C-terminal 
area  (CH4  homology  region)  is  free  of  carbohydrate  and  is  very  rich  in 
hydrophobic amino acids (17). This may relate to the postulated attachment and 
partial  burial of the  C-terminal portion  of the  IgM  heavy chains in the lipid 
moieties  of the  membrane.  It  is  certainly clear  that  the  Fab  portion  of the 
molecule is on the outer surface of the membrane and is available for antigen 
binding as well as for all the Fab-specific antibodies utilized in the present study. 
In addition the sites reacting with idiotypic antibodies are clearly available (18). 
Summary 
Hemagglutination and  fluorescent antibody studies have  provided strong evi- 
dence for the unavailability or absence of specific antigenic sites on membrane- 
bound IgM which are present in serum and intracellular IgM. Antisera specific 
for different parts of the molecule indicated that a portion but not all of the Fc 
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was  involved.  Absorption  experiments  with  normal  and  leukemic  viable  B 
lymphocytes failed to remove a population of Fc antibodies found in IgM-specific 
antisera.  Similar  findings  were  made  for  IgD,  the  other  major  membrane 
immunoglobulin of human  peripheral  blood B  cells.  Various interpretations  of 
these  observations  are  discussed.  The  most  likely  possibility  appears  that  the 
C-terminal portion of the heavy chains of the immunoglobulin molecule is buried 
in the membrane. 
We thank Dr. R. B. Hester for his generous gift of fragments from CH4 region of p-chain. Miss Ruth 
Brook's excellent technical assistance is appreciated. We thank Dr. R. J. Winchester for a number of 
antisera and fruitful discussions during this investigation. 
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